Search results
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Pharming Group N.V.'s (NASDAQ: PHAR) Joenja (leniolisib) for activated...
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...
Pharming Highlights Interim Data From Rare Immune Deficiency Study
Benzinga via Yahoo Finance· 1 year agoPharming Group N.V. (NASDAQ: PHAR) announced data from an interim analysis of its open-label...